From the Department of Nuclear Medicine.
Biometrics Research Branch.
Clin Nucl Med. 2019 Jan;44(1):21-29. doi: 10.1097/RLU.0000000000002348.
The aim of this study was to develop a combined statistical model using both clinicopathological factors and texture parameters from F-FDG PET/CT to predict responses to neoadjuvant chemotherapy in patients with breast cancer.
A total of 435 patients with breast cancer were retrospectively enrolled. Clinical and pathological data were obtained from electronic medical records. Texture parameters were extracted from pretreatment FDG PET/CT images. The end point was pathological complete response, defined as the absence of residual disease or the presence of residual ductal carcinoma in situ without residual lymph node metastasis. Multivariable logistic regression modeling was performed using clinicopathological factors and texture parameters as covariates.
In the multivariable logistic regression model, various factors and parameters, including HER2, histological grade or Ki-67, gradient skewness, gradient kurtosis, contrast, difference variance, angular second moment, and inverse difference moment, were selected as significant prognostic variables. The predictive power of the multivariable logistic regression model incorporating both clinicopathological factors and texture parameters was significantly higher than that of a model with only clinicopathological factors (P = 0.0067). In subgroup analysis, texture parameters, including gradient skewness and gradient kurtosis, were selected as independent prognostic factors in the HER2-negative group.
A combined statistical model was successfully generated using both clinicopathological factors and texture parameters to predict the response to neoadjuvant chemotherapy. Results suggest that addition of texture parameters from FDG PET/CT can provide more information regarding treatment response prediction compared with clinicopathological factors alone.
本研究旨在开发一种联合统计模型,结合临床病理因素和 F-FDG PET/CT 的纹理参数,预测乳腺癌患者对新辅助化疗的反应。
回顾性纳入 435 例乳腺癌患者。临床和病理数据来自电子病历。从预处理 FDG PET/CT 图像中提取纹理参数。终点为病理完全缓解,定义为无残留疾病或存在残留导管原位癌而无残留淋巴结转移。使用多变量逻辑回归模型,以临床病理因素和纹理参数作为协变量。
在多变量逻辑回归模型中,HER2、组织学分级或 Ki-67、梯度峰度、梯度峰度、对比度、差异方差、角二阶矩和倒数矩等各种因素和参数被选为重要的预后变量。纳入临床病理因素和纹理参数的多变量逻辑回归模型的预测能力明显高于仅包含临床病理因素的模型(P = 0.0067)。在亚组分析中,梯度峰度和梯度峰度等纹理参数被选为 HER2 阴性组的独立预后因素。
成功地建立了一种联合统计模型,将临床病理因素和纹理参数结合起来,预测新辅助化疗的反应。结果表明,与单独的临床病理因素相比,添加 FDG PET/CT 的纹理参数可以提供更多关于治疗反应预测的信息。